New purchase CapsoVision

📈 New purchase - CapsoVision

I am with CapsoVision
$CV an innovative MedTech company that is setting new standards with its 360° capsule endoscopy. No external recorder required, full perspective - and already FDA-approved & in use in the USA.

💡 Why this investment?

Technological advantage compared to traditional solutions (e.g. PillCam from Medtronic)
Already cooperating with Pentax Medical
Focus on early detection & diagnosticsa megatrend in the healthcare sector
Low market capitalization (~180m USD) with a lot of upside potential

🚀 Vision:

If CapsoVision reaches USD 50-100m sales in the medium term, a multiple in the share price is possible. In the long term I see 10-25 USD+ per share as realistic - depending on market penetration and access to capital, of course.

I think: exciting small cap story with disruptive potential - What do you think?

👉 Do you know the company? How do you rate the opportunities & risks?

Please leave your opinion!

#aktien
#investieren
#MedTech
#CapsoVision
#SmallCap
#langfristig
#innovation
#getquin
#medizin
#medizintechnik
#pharma
#medical
#zukunft
$NOVO B (+0,56 %)
$PLTR (-0,29 %)
$AMD (-0,94 %)
$NOVN (+0,68 %)

Chris@Multibagger

2Semana

Interesting. Is there a reason why it has fallen so much since you joined?

•

mr.salva@mrsalva

@Multibagger Interesting question. For me, this is more of a consolidation after the IPO hype. Operationally, CapsoVision is growing at a double-digit rate, has fresh capital (USD 23 million) thanks to the IPO and is working on products with great market potential. The decisive catalyst remains the approval of the Colon capsule. 510(k) decision expected in Q1 2026. Until then, investors are likely to be somewhat cautious.